HRP20210814T1 - Derivati piridokinazolina korisni kao inhibitori proteinskih kinaza - Google Patents
Derivati piridokinazolina korisni kao inhibitori proteinskih kinaza Download PDFInfo
- Publication number
- HRP20210814T1 HRP20210814T1 HRP20210814TT HRP20210814T HRP20210814T1 HR P20210814 T1 HRP20210814 T1 HR P20210814T1 HR P20210814T T HRP20210814T T HR P20210814TT HR P20210814 T HRP20210814 T HR P20210814T HR P20210814 T1 HRP20210814 T1 HR P20210814T1
- Authority
- HR
- Croatia
- Prior art keywords
- pyrido
- quinazoline
- carboxamide
- oxo
- unbranched
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F24—HEATING; RANGES; VENTILATING
- F24C—DOMESTIC STOVES OR RANGES ; DETAILS OF DOMESTIC STOVES OR RANGES, OF GENERAL APPLICATION
- F24C7/00—Stoves or ranges heated by electric energy
- F24C7/08—Arrangement or mounting of control or safety devices
- F24C7/082—Arrangement or mounting of control or safety devices on ranges, e.g. control panels, illumination
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F24—HEATING; RANGES; VENTILATING
- F24C—DOMESTIC STOVES OR RANGES ; DETAILS OF DOMESTIC STOVES OR RANGES, OF GENERAL APPLICATION
- F24C7/00—Stoves or ranges heated by electric energy
- F24C7/08—Arrangement or mounting of control or safety devices
- F24C7/087—Arrangement or mounting of control or safety devices of electric circuits regulating heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Combustion & Propulsion (AREA)
- Mechanical Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201730759 | 2017-06-01 | ||
| EP18759146.6A EP3632912B1 (en) | 2017-06-01 | 2018-05-31 | Pyridoquinazoline derivatives useful as protein kinase inhibitors |
| PCT/ES2018/070396 WO2018220252A1 (es) | 2017-06-01 | 2018-05-31 | Derivados de piridoquinazolina eficaces como inhibidores de proteína quinasa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20210814T1 true HRP20210814T1 (hr) | 2021-06-25 |
Family
ID=61569288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20210814TT HRP20210814T1 (hr) | 2017-06-01 | 2018-05-31 | Derivati piridokinazolina korisni kao inhibitori proteinskih kinaza |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US11021479B2 (enExample) |
| EP (1) | EP3632912B1 (enExample) |
| JP (1) | JP7110335B2 (enExample) |
| KR (1) | KR102629854B1 (enExample) |
| CN (1) | CN111247143B (enExample) |
| AU (1) | AU2018278283B2 (enExample) |
| CY (1) | CY1124087T1 (enExample) |
| DK (1) | DK3632912T3 (enExample) |
| EA (1) | EA037384B1 (enExample) |
| ES (1) | ES2881960T3 (enExample) |
| HR (1) | HRP20210814T1 (enExample) |
| HU (1) | HUE054792T2 (enExample) |
| LT (1) | LT3632912T (enExample) |
| MX (1) | MX385475B (enExample) |
| PL (1) | PL3632912T3 (enExample) |
| PT (1) | PT3632912T (enExample) |
| RS (1) | RS61833B1 (enExample) |
| SI (1) | SI3632912T1 (enExample) |
| SM (1) | SMT202100312T1 (enExample) |
| WO (1) | WO2018220252A1 (enExample) |
| ZA (1) | ZA201908372B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11978921B2 (en) | 2020-01-31 | 2024-05-07 | Lg Energy Solution, Ltd. | Method of manufacturing separator-composite electrode comprising multilayer-structured inorganic layer and separator-composite electrode manufactured thereby |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4551460A (en) | 1982-05-10 | 1985-11-05 | Hoffmann-La Roche Inc. | Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis |
| WO1998023617A1 (en) | 1996-11-26 | 1998-06-04 | American Cyanamid Company | Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents |
| WO2005048953A2 (en) | 2003-11-13 | 2005-06-02 | Ambit Biosciences Corporation | Amide derivatives as kinase modulators |
| AU2008345225A1 (en) * | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| KR101361027B1 (ko) | 2008-11-28 | 2014-02-11 | 코와 가부시키가이샤 | 피리딘-3-카르복시아미드 유도체 |
| EP3778600A1 (en) | 2014-03-20 | 2021-02-17 | The Johns Hopkins University | Compounds which inhibit rna polymerase, compositions including such compounds, and their use |
-
2018
- 2018-05-31 RS RS20210545A patent/RS61833B1/sr unknown
- 2018-05-31 SM SM20210312T patent/SMT202100312T1/it unknown
- 2018-05-31 AU AU2018278283A patent/AU2018278283B2/en active Active
- 2018-05-31 LT LTEP18759146.6T patent/LT3632912T/lt unknown
- 2018-05-31 WO PCT/ES2018/070396 patent/WO2018220252A1/es not_active Ceased
- 2018-05-31 MX MX2019014436A patent/MX385475B/es unknown
- 2018-05-31 CN CN201880048531.4A patent/CN111247143B/zh active Active
- 2018-05-31 JP JP2020516962A patent/JP7110335B2/ja active Active
- 2018-05-31 DK DK18759146.6T patent/DK3632912T3/da active
- 2018-05-31 KR KR1020197038842A patent/KR102629854B1/ko active Active
- 2018-05-31 EP EP18759146.6A patent/EP3632912B1/en active Active
- 2018-05-31 EA EA201992793A patent/EA037384B1/ru unknown
- 2018-05-31 PL PL18759146T patent/PL3632912T3/pl unknown
- 2018-05-31 HR HRP20210814TT patent/HRP20210814T1/hr unknown
- 2018-05-31 SI SI201830289T patent/SI3632912T1/sl unknown
- 2018-05-31 HU HUE18759146A patent/HUE054792T2/hu unknown
- 2018-05-31 US US16/615,867 patent/US11021479B2/en active Active
- 2018-05-31 ES ES18759146T patent/ES2881960T3/es active Active
- 2018-05-31 PT PT187591466T patent/PT3632912T/pt unknown
-
2019
- 2019-12-13 ZA ZA2019/08372A patent/ZA201908372B/en unknown
-
2021
- 2021-05-20 CY CY20211100437T patent/CY1124087T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SMT202100312T1 (it) | 2021-07-12 |
| EA201992793A1 (ru) | 2020-03-26 |
| US11021479B2 (en) | 2021-06-01 |
| EP3632912B1 (en) | 2021-03-17 |
| PT3632912T (pt) | 2021-06-02 |
| HUE054792T2 (hu) | 2021-09-28 |
| RS61833B1 (sr) | 2021-06-30 |
| CN111247143B (zh) | 2022-07-05 |
| MX385475B (es) | 2025-03-18 |
| EA037384B1 (ru) | 2021-03-23 |
| PL3632912T3 (pl) | 2021-09-06 |
| ZA201908372B (en) | 2021-04-28 |
| BR112019024892A2 (pt) | 2020-06-16 |
| US20200148676A1 (en) | 2020-05-14 |
| CA3066009A1 (en) | 2018-12-06 |
| KR102629854B1 (ko) | 2024-01-25 |
| JP2020521817A (ja) | 2020-07-27 |
| WO2018220252A1 (es) | 2018-12-06 |
| AU2018278283A1 (en) | 2019-12-19 |
| KR20200011990A (ko) | 2020-02-04 |
| SI3632912T1 (sl) | 2021-08-31 |
| JP7110335B2 (ja) | 2022-08-01 |
| MX2019014436A (es) | 2020-02-10 |
| CN111247143A (zh) | 2020-06-05 |
| EP3632912A1 (en) | 2020-04-08 |
| LT3632912T (lt) | 2021-06-10 |
| CY1124087T1 (el) | 2022-05-27 |
| AU2018278283B2 (en) | 2021-06-17 |
| DK3632912T3 (da) | 2021-05-10 |
| ES2881960T3 (es) | 2021-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2931085C (en) | Cyclic sulfone and sulfoximine analogs and uses thereof | |
| CA2903288C (en) | N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities | |
| ES2630705T3 (es) | Compuestos de piridilo sustituidos con triazolilo útiles como inhibidores de cinasas | |
| ES2823477T3 (es) | Aril éteres y usos de los mismos | |
| AU2015313782B2 (en) | Compounds and compositions as RAF kinase inhibitors | |
| JP6294954B2 (ja) | Ｐ２ｘ７調節物質 | |
| HRP20201985T1 (hr) | Piridonski spoj kao c-met inhibitor | |
| ES2989149T3 (es) | Inhibidores de HAT p300/CBP | |
| ME02672B (me) | Fenil-3-aza-bicikl0[3.1.0]heks-3-il-metanoni i njihova primena kao medikament | |
| JP2017511357A5 (enExample) | ||
| JP2016534134A5 (enExample) | ||
| RU2019104890A (ru) | Замещенные тиазолопиридиновые соединения в качестве ингибиторов malt1 | |
| HRP20210869T1 (hr) | Pripravci spojeva i njihova upotreba | |
| ME02667B (me) | Spiro-prstenasti spoj koji sadrži dušik i njegova upotreba u medicini | |
| CA2764728A1 (en) | Janus kinase inhibitor compounds and methods | |
| WO2020031107A1 (en) | Chemical compounds | |
| WO2019060611A1 (en) | CYCLIC IMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF KINASES | |
| JP2020525512A (ja) | 癌および他の疾患を処置するためのＡＴＦ４阻害剤としての２−（４−クロロフェノキシ）−Ｎ−（（１−（２−（４−クロロフェノキシ）エチンアゼチジン（ｅｔｈｙｎａｚｅｔｉｄｉｎ）−３−イル）メチル）アセトアミド誘導体および関連化合物 | |
| JP2016501185A5 (enExample) | ||
| HRP20220472T1 (hr) | Novi derivati heteroarilamida kao selektivni inhibitori histonskih deacetilaza 1 i 2 (hdac1-2) | |
| HRP20180973T1 (hr) | Supstituirani tiazolski ili oksazolski antagonisti p2x7 receptora | |
| RU2016112963A (ru) | Новые производные триазолопиразина и их применение | |
| WO2024120471A1 (en) | Compounds targeting mutant of p53 | |
| JP2015502371A5 (enExample) | ||
| JP2019510801A5 (enExample) |